Other
Thrombectomy
0
Pipeline Programs↗
6
Active Trials↗
0
Companies Involved↗
Thrombectomy is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
16
clinical trials
Completed4 · 25%
Recruiting4 · 25%
Unknown status4 · 25%
Not yet recruiting2 · 13%
Suspended1 · 6%
Terminated1 · 6%
Clinical Trials
Trial Activity
16 trials
Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy (ALLY) II Trial
Recruiting·—·Phase 2/3·NCT06949228·132 enrolled
Study on Hibernation-like Therapy Based on Mechanical Thrombectomy
Recruiting·—·Phase 1·NCT06663631·32 enrolled
Reperfusion Completion Via Local Arterial Infusion of Tenecteplase After Incomplete Mechanical Thrombectomy
Not yet recruiting·—·Phase 3·NCT07471282·344 enrolled
Direct Mechanical Thrombectomy Versus Bridging Therapy
Completed·—·Phase 4·NCT05155540·51 enrolled
Adjunctive Intra-arterial Tenecteplase Following Mechanical Thrombectomy Pilot Trial
Completed·—·Phase 2·NCT05172934·20 enrolled
Short-duration Selective Brain Cooling for Patients Undergoing Mechanical Thrombectomy
Suspended·—·Phase 2/3·NCT03163459·120 enrolled
Tenecteplase Compared to Alteplase for Patients With Large Vesel Oclusion Suspicion Before Thrombectomy
Unknown status·HHospital Universitari Vall d'Hebron Research Institute·Phase 3·NCT05626972·500 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)